Is Biogen Inc (NASDAQ: BIIB) No Longer A Good Investment?

After Hours

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.

Stocks Info

BIIB belongs to the Healthcare sector of the NASDAQ while operating in the Drug Manufacturers – General industry. The current market capitalization of Biogen Inc is $17.05B. A total of 1.76 million shares were traded on the day, compared to an average of 1.72M shares.

In the most recent transaction, SHERWIN STEPHEN A sold 8,760 shares of BIIB for 150.02 per share on Mar 07 ’25. After the transaction, the Director now owns 11,318 company shares. In a previous transaction on Mar 07 ’25, STEPHEN A SHERWIN bought 8,760 shares at 147.37 per share.

Among the insiders who sold shares, Singhal Priya disposed of 110 shares on Dec 09 ’24 at a per-share price of $157.21. This resulted in the Head of Development holding 5,426 shares of BIIB after the transaction. In another insider transaction, Singhal Priya bought 110 shares at $157.21 per share on Dec 09 ’24.

While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, BIIB has a high of $238.00 and a low of $110.04.

As of this writing, BIIB has an earnings estimate of $3.15 per share for the current quarter. EPS was calculated based on a consensus of 24.0 estimates, with a high estimate of $4.03 per share and a lower estimate of $1.94.

Balance Sheet Annually/Quarterly

An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. BIIB’s latest balance sheet shows that the firm has $3.80B in Cash & Short Term Investments as of fiscal 2021. There were $7.60B in debt and $4.30B in liabilities at the time. Its Book Value Per Share was $114.65, while its Total Shareholder’s Equity was $10.96B.

Analysts Opinion

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for BIIB is Buy with a score of 3.88.

Most Popular

Related Posts